Share this with FacebookShare this with TwitterShare this with LinkedInEmail this pagePrint this page
KSHB: Kansas City doctors weigh in on Pfizer COVID-19 vaccine trial success
Pharmaceutical company Pfizer announced its COVID-19 vaccine trial is showing a lot of promise.
KSHB talked to Dr. Andrew Schlachter, a pulmonologist and critical care physician with Saint Luke's, about the early findings and what this means moving forward.
Watch the full story below.